Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > TLT is working with FDA on BTD

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Aug 30, 2023 11:04am

185 Views

Post# 35611893

RE:RE:RE:RE:TLT is working with FDA on BTD

Clearly if data was not good enough, I believe the FDA would have stated so by now.. Probably it's the FDA required format which needs to be completed for preBTD and BTD. Adstiladrin approved a few months ago at 24% CR and 4 treatments with more side effects, we have 33% CR and less treatments and side effects, hard to believe we shouldn't get BTD followed by AA. IMHO

<< Previous

Bullboard Posts

Next >>

Bombardier Defense expands in Australia